Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: A prospective randomized trial

Fertility and Sterility

Volumn 97, Issue 6, 2012, Pages

  Cédrin Durnerin, Isabelle ^a   Guivarc'H Levêque, Anne ^b   Hugues, Jean Noël ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b Clinique mutualiste La Sagesse   (France)

Author keywords

ART; estrogen pretreatment; GnRH antagonist; ovarian stimulation

Indexed keywords

ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; PROVAMES; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; CLINICAL PRACTICE; CONTROLLED STUDY; DELIVERY; DRUG EFFICACY; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OOCYTE; PREGNANCY RATE; PREGNANCY TEST; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT DURATION;

EID: 84861633392     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.02.028     Document Type: Article

References (24)

1. P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, and E. Kolibianakis Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment Hum Reprod 24 2009 764 774
2. H.G. Al-Inany, M.A.F.M. Youssef, M. Aboulghar, F. Broekmans, M. Sterrenburg, and J. Smit Gonadotrophin-releasing hormone antagonists for assisted reproductive technology Cochrane Database Syst Rev 5 2011 CD001750
3. G. Griesinger, R. Felderbaum, and K. Diedrich GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians'second choice? Data from the german national IVF registry Hum Reprod 20 2005 2373 2375
4. H.G. Al-Inany, A.M. Abbou Setta, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review Reprod Biomed Online 14 2007 640 649
5. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum Reprod Update 12 2007 651 671
6. L.I. Barmat, S.J. Chantilis, B.S. Hurst, and R.P. Dickey A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization Fertil Steril 83 2005 321 330
7. G. Griesinger, C.A. Venetis, T. Marx, K. Diedrich, B.C. Tarlatzis, and E.M. Kolibianakis Oral contraceptive pill pre-treatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis Fertil Steril 90 2008 1055 1063
8. B. Smulders, S.M. van Oirschot, C. Farquhar, L. Rombauts, and J.A.M. Kremer Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques [review] Cochrane Database Syst Rev 1 2010 CD006109
9. I. Cédrin-Durnerin, S. Bulwa, F. Hervé, B. Martin-Pont, M. Uzan, and J.N. Hugues The hormonal flare-up following GnRH agonist administration is influenced by a progestogen pre-treatment Hum Reprod 11 1996 1859 1863
10. R. Fanchin, J.S. Cunha-Filho, L.M. Schonaeur, I.J. Kadoch, P. Cohen Bacri, and R. Frydman Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens Fertil Steril 79 2003 316 321
11. I. Cédrin-Durnerin, B. Bständig, I. Parneix, V. Bied-Damon, C. Avril, and C. Decanter Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol Hum Reprod 22 2007 109 116
12. J.A. Huirne, J.N. Hugues, C. Pirard, F. Fischl, J.C. Sage, and J.L. Pouly Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study Hum Reprod 21 2006 1408 1415
13. L. Rombauts, D. Healy, R.J. Norman Orgalutran Scheduling Study Group A comparative randomized trial to assess the impact of oral contraceptive pre-treatment on follicular growth and hormone profiles in GnRH antagonist-treated patients Hum Reprod 21 2006 95 103
14. J.S. Cunha Filho, L.F. Terres, F. Holanda, F. Freitas, C. Glitz, and V.K. Genro Luteal phase administration in ovarian stimulation cycles with antagonist is comparable to the GnRH agonist (long) protocol J Assist Reprod Genet 24 2007 326 330
15. 2) pre-treatment before GnRH antagonist protocol and standard long agonist protocol: a prospective and randomized study J Assist Reprod Genet 26 2009 105 111
16. E.M. Kolibianakis, E.G. Papanikolaou, M. Camus, H. Tournaye, A.C. van Steirteghem, and P. Devroey Effect of oral contraceptive pill pre-treatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial Hum Reprod 21 2006 352 357
17. A. Nyboe Andersen, H. Witjes, K. Gordon, B. Mannaerts Xpect Investigators Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment Hum Reprod 12 2011 3413 3423
18. H. Pinkas, O. Sapir, O.M. Avrech, A. Ben-Haroush, J. Ashkenzi, and B. Fisch The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome J Assist Reprod Genet 25 2008 29 33
19. J. Bellver, C. Albert, E. Labarta, and A. Pellicer Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pre-treatment Fertil Steril 87 2007 1098 1101
20. D.R. Meldrum, R.T. Scott, M.J. Levy, M.M. Alper, and N. Noyes Oral contraceptive pre-treatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss Fertil Steril 91 2009 1963 1965
21. E.M. Kolibianakis, K. Zikopoulous, J. Schiettecatte, J. Smitz, H. Tournaye, and M. Camus Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF Hum Reprod 19 2004 2490 2496
22. J.A.F. Huirne, A.C.D. van Loenen, R. Schats, J. McDonnell, P.G.A. Hompes, and J. Schoemaker Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal change in LH and progesterone for clinical pregnancy Hum Reprod 20 2005 359 367
23. K.J. Doody, P. Devroey, A. Leader, H. Witges, and B.M. Mannaerts No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part1, corifollitropin alpha RBM Online 23 2011 449 456
24. A. Guivarc'h-Levêque, L. Homer, P. Arvis, P.L. Broux, L. Moy, and G. Priou Programming in vitro fertilization retrievals during working days after gonadotropin releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes? Fertil Steril 96 2011 872 876